- Men and women who are regular smokers.
Sound like you?
If you would like to learn more about the Varenicline-Bupropion Study,
- e-mail: oliv0190@umn.edu or
- call: 612-627-1018
The purpose of this study is to test how two medications to quit smoking work, alone and together. The two medications are called: (1) bupropion, also called Zyban®, and (2) varenicline, also called Chantix®. Both of these medications are approved by the United States Food and Drug Administration (FDA) to help people quit smoking. This study will test how bupropion, varenicline, and the two medications taken together, bupropion plus varenicline, work by having you quit smoking and complete tasks that assess how you think and feel.
There are at total of 9 visits in this study. They happen over a 6-week period.
If you agree to be in this study, you will attend 9 visits for the next 6 weeks. You will quit smoking two times in this study. You will quit for 8 hours each time. At each clinic visit you will complete several questionnaires asking about withdrawal symptoms, smoking satisfaction, mood, health and medication use. At one visit, we will collect a blood sample.
You will receive up to $424 for your time spent participating if you comply with all of the study requirements.
Let us know. Either call 612-627-1018 or email: oliv0910@umn.edu
IRB Code: 0809M45561